SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-067140
Filing Date
2020-03-09
Accepted
2020-03-09 16:01:35
Documents
3
Period of Report
2020-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836594d8k.htm 8-K 17906
2 EX-99.1 d836594dex991.htm EX-99.1 89648
3 GRAPHIC g836594g39u89.jpg GRAPHIC 5898
  Complete submission text file 0001193125-20-067140.txt   117017
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 20697947
SIC: 2834 Pharmaceutical Preparations